Safety, Tolerability and Pharmacokinetics of BIIB118 (PF-05251749)
Status:
Completed
Trial end date:
2015-10-31
Target enrollment:
Participant gender:
Summary
This is a First in human (FIH) single ascending dose study to evaluate the safety,
tolerability and pharmacokinetics (PKs) of BIIB118 following single oral doses in healthy
human subjects